Canada: Life Sciences, Biotechnology & Nanotechnology

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Life Sciences-Health Canada Takes Action Against Unauthorized Peptide Sales
On July 29, 2026, Health Canada announced that it had obtained a permanent injunction against a Québec-based company in connection with the sale of unauthorized injectable peptides in Canada. The announcement reflects Health Canada’s continued focus on peptide products and serves as a reminder that injectable peptides intended for human use are regulated as prescription drugs and are subject to Canada's drug regulatory framework.
Canada Healthcare
F
Fasken
Article
Pharmaceutical And Life Sciences Sector Federal Task Force Releases Final Report
On July 24, 2026, Health Canada published the Final Report of the Pharmaceutical and Life Sciences Sector Task Force to the Ministers of Health and Industry. The Task Force was launched in March 2026 as a joint federal initiative of Health Canada and Innovation, Science and Economic Development Canada. The Task Force’s mandate was to support reliable and sustainable access to pharmaceutical products in Canada and identify made-in-Canada solutions that drive innovation, competitiveness and long-term growth in the life sciences sector.
Canada Healthcare
F
Fasken
Article
Santé Canada Renforce Le Cadre De Gestion Des Pénuries De Médicaments Et D’instruments Médicaux
Le 17 juin 2026, Santé Canada a publié le Règlement modifiant certains règlements pris en vertu de la Loi sur les aliments et drogues (pénuries et cessation de la vente de drogues et d’instruments médicaux) (le « Règlement modificatif »), qui apporte des modifications au Règlement sur les aliments et drogues (RAD) et au Règlement sur les instruments médicaux (RIM).
Canada Healthcare
FF
Fasken (French)
Article
Les faits saillants du premier semestre de 2026 au Canada en matière de PI en sciences de la vie et de droit réglementaire
L'équipe responsable des mises à jour PI Rx examine les développements majeurs en propriété intellectuelle et en droit réglementaire des sciences de la vie au Canada durant le premier semestre 2026, incluant les nouvelles lignes directrices de la Cour fédérale, les initiatives de Santé Canada et les mises à jour du CEPMB et de l'AMC.
Canada Healthcare
SB
Smart & Biggar
Article
Canadian Governments Invest In Innovation, Talent And Domestic Competitiveness
A convergence of geopolitical shifts, trade uncertainty and heightened industrial policy ambition has fundamentally altered the operating environment for Canadian businesses. How are federal and provincial governments responding with new funding programs, capital sources and talent initiatives to support the retention and growth of technology, intellectual property and human capital in Canada? This comprehensive overview examines recent strategic initiatives spanning artificial intelligence, life sciences,
Canada Finance
BC
Blake, Cassels & Graydon LLP
See more

Latest Videos

See more